跳至主要内容
临床试验/NCT02206945
NCT02206945已完成不适用

Neurofeedback of Activity in the Orbitofrontal Cortex for OCD

Yale University1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2015年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
1
主要终点
A modified version of the Yale-Brown Obsessive-Compulsive Symptom scale (Y-BOCS) will be used, that queries subjects regarding symptoms

研究概览

简要总结

The aim of this study is to train patients with obsessive-compulsive disorder to control a region of their brain that has been associated with their symptoms. Patients in the experimental group will be given direct feedback regarding activity in this brain area while they are undergoing functional magnetic resonance imaging (fMRI) scanning, and will try to learn to control activity in the region during these feedback sessions. A separate group of patients will be given a control form of feedback that we do not believe can have clinical benefits. Our primary hypothesis is that the neurofeedback training will reduce OCD symptoms more than the control feedback.

详细描述

Original study design recruiting controls who were matched to the experimental group was changed to a randomized design prior to enrollment of the first participant.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Primary Diagnosis of Current OCD, based on Diagnostic and Statistical Manual (DSM-IV) criteria, a Y-BOCS (Yale-Brown Obsessive-Compulsive Scale) score >=16
  • •Principle OCD symptoms- Primary symptoms must be either Cleaning/Contamination or Checking; other symptoms okay
  • •Unmedicated (or medications stable for 8 weeks).
  • •Research group must be able to identify a target region in the orbitofrontal cortex that is related to symptoms

排除标准

  • •Active Psychosis; Pervasive Developmental Disorder ; epilepsy or other major neurological disorder
  • •History of major head trauma or psychosurgery
  • •Active Substance Abuse within 6 months
  • •Seizure disorder or other significant neurological disorder
  • •Active Suicidality
  • •Pregnancy
  • •severe claustrophobia, ferromagnetic metal in the body, a pacemaker or defibrillator, or any other condition that would make MRI scanning unsafe or inappropriate
  • •any psychotropic medication other than a selective serotonin reuptake inhibitor (SSRI) antidepressant, anafranil, or a low-dose hypnotic or anxiolytic taken on an as-needed basis
  • •active cognitive/behavioral therapy initiated within the last 3 months (continuation of established maintenance therapy that has been going on for longer than 3 months will not be grounds for exclusion)

研究组 & 干预措施

neurofeedback

Experimental

Two imaging sessions of neurofeedback.

干预措施: neurofeedback (Behavioral)

control feedback

Placebo Comparator

Two imaging sessions of feedback

干预措施: control feedback (Behavioral)

结局指标

主要结局

A modified version of the Yale-Brown Obsessive-Compulsive Symptom scale (Y-BOCS) will be used, that queries subjects regarding symptoms

时间窗: Approximately 4 days post-intervention

A modified version of the Yale-Brown Obsessive-Compulsive Symptom scale (Y-BOCS) will be used, that queries subjects regarding symptoms

时间窗: Immediately before intervention

次要结局

  • Control over target brain area(Approximately 4 days pre-intervention)
  • Control over the target brain area.(Approximately 4 days post-intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验